Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs

被引：2
|
作者：
Holden, Sarah E. [1 ]
Bannister, Christian A. [1 ]
Currie, Craig J. [1 ]
机构：
[1] Cardiff Univ, Cardiff Medictr, Pharma Res Ctr, Sch Med, Cardiff CF14 4UJ, S Glam, Wales
来源：
DIABETOLOGIA | 2014年 / 57卷 / 09期
基金：
英国医学研究理事会;
关键词：
Cancer; Diabetes; Diabetes duration; Insulin; Mortality; Treatment;
D O I：
10.1007/s00125-014-3281-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2001 / 2002
页数：2
相关论文
共 50 条
  • [31] Effects of novel glucose-lowering drugs on the COVID-19 patients with diabetes: A network meta-analysis of clinical outcomes
    Yang, Yang
    Zhao, Ling
    Wang, Yeying
    Liu, Chengjiang
    Ke, Tingyu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (03) : 426 - 436
  • [32] Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register
    Ekstrom, N.
    Miftaraj, M.
    Svensson, A. -M.
    Sundell, K. Andersson
    Cederholm, J.
    Zethelius, B.
    Gudbjornsdottir, S.
    Eliasson, B.
    DIABETES OBESITY & METABOLISM, 2012, 14 (08) : 717 - 726
  • [33] Factors Influencing the Choice of Glucose-Lowering Medications Among Physicians Treating Patients With Type 2 Diabetes
    AlSofiani, Mohammed E.
    AlHalees, Danah Z.
    Aljebreen, Joud A.
    Abu Dahesh, Joud A.
    Bamogaddam, Ghada S.
    AlBraithen, Ghaida M.
    Jammah, Anwar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [34] Glucose-Lowering Drugs with Proven Cardiovascular Benefit Following Acute Coronary Syndrome in Patients with Type 2 Diabetes: Treatment Gaps and Outcomes
    Naoum, Ibrahim
    Saliba, Walid
    Barnett-Griness, Ofra
    Aker, Amir
    Zafrir, Barak
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [35] Initiation and Persistence to Statin Treatment in Patients with Diabetes Receiving Glucose-Lowering Medications 1997-2006
    Dominguez, H.
    Schramm, T. K.
    Norgaard, M. L.
    Abildstrom, S. Z.
    Kober, L.
    Jorgensen, C.
    Guterbaum, T. J.
    Poulsen, H. E.
    Torp-Pedersen, C.
    Gislason, G. H.
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2009, 3 : 152 - 159
  • [36] The Impact of Glucose-Lowering Strategy on the Risk of Increasing Frailty Severity among 49,519 Patients with Diabetes Mellitus: A Longitudinal Cohort Study
    Chi, Chun-Yi
    Wang, Jui
    Lee, Szu-Ying
    Chao, Chia-Ter
    Hung, Kuan-Yu
    Chien, Kuo-Liong
    AGING AND DISEASE, 2023, 14 (05): : 1917 - 1926
  • [37] Diabetes mellitus and cystic fibrosis:: Comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents
    Rosenecker, J
    Eichler, I
    Bärmeier, H
    von der Hardt, H
    PEDIATRIC PULMONOLOGY, 2001, 32 (05) : 351 - 355
  • [38] Arginase inhibition improves endothelial function in patients with type 2 diabetes mellitus despite intensive glucose-lowering therapy
    Mahdi, A.
    Kovamees, O.
    Checa, A.
    Wheelock, C. E.
    von Heijne, M.
    Alvarsson, M.
    Pernow, J.
    JOURNAL OF INTERNAL MEDICINE, 2018, 284 (04) : 388 - 398
  • [39] Utilisation and expenditure on glucose-lowering drugs used for the treatment of type 2 diabetes mellitus in Ireland, a repeated cross- sectional study
    Smith, Amelia
    Kennedy, Carmel
    Clarke, Sarah
    Barry, Michael
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2022, 5
  • [40] What Characteristics at Baseline Are Associated with the Glucose-lowering Effect of Colestimide in Patients with Type 2 Diabetes and Hypercholesterolemia According to Response to Treatment?
    Suzuki, Tatsuya
    Tsunoda-Kubota, Misako
    Aoyama, Junya
    Futami-Suda, Shoko
    Hashimoto, Masao
    Igari, Yoshimasa
    Watanabe, Kentaro
    Kigawa, Yoshiaki
    Nakano, Hiroshi
    Oba, Kenzo
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2013, 80 (03) : 211 - 217
12345